BioSpace News Archive

Adaptive Research, a pioneering organization committed to democratizing clinical trials by offering comprehensive support to community-based trial investigators, announced a landmark agreement with Florida Theranostics.

Precision BioSciences, Inc. today announced that its partner iECURE has received approval from the Australian Therapeutic Goods Administration for the initiation of a first-in-human Phase 1/2 trial evaluating ECUR-506, incorporating an ARCUS nuclease for the treatment of Ornithine Transcarbamylase (OTC) deficiency in pediatric (or neonatal) patients.

Kineta, Inc. announced today the peer-reviewed publication in Frontiers in Immunology of preclinical data highlighting the potential of KVA12123 as a new immunotherapy against poorly immunogenic tumors.

RenovoRx, Inc. announced today that the Company has filed an international patent application under the Patent Cooperation Treaty (PCT) for its novel Trans-Arterial Micro-Perfusion (TAMP) therapy platform.

Veranex today announced that it has acquired T3 Labs, a highly reputable preclinical laboratory located in Atlanta, Georgia.

Alveo Technologies, Inc., a leader in molecular sensing and diagnostics with its proprietary technology platform, announced 19 new distributor partnerships across Europe, Africa, and the Middle East.

Pipeline Therapeutics, Inc. (the Company) announced today that it has changed its name to Contineum Therapeutics, Inc. (Contineum).

Metrodora Institute, a leading multispecialty healthcare institute, announces the appointment of Brent P. Goodman, MD, as Chief Medical Officer.

United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger.

The global pharmaceutical contract manufacturing and research services market size is estimated to hit around USD 435.53 billion by 2032 and the sector is expanding at a notable CAGR of 7.3% from 2023 to 2032.